These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin. Bonventre PF; Weckbach L; Harth G; Haidaris C Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656 [TBL] [Abstract][Full Text] [Related]
3. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus. Lee JC; Liu MJ; Parsonnet J; Arbeit RD J Clin Microbiol; 1990 Dec; 28(12):2612-5. PubMed ID: 2279990 [TBL] [Abstract][Full Text] [Related]
4. Toxic shock syndrome in Britain--epidemiology and microbiology. de Saxe MJ; Hawtin P; Wieneke AA Postgrad Med J; 1985; 61 Suppl 1():5-21. PubMed ID: 4059160 [TBL] [Abstract][Full Text] [Related]
5. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome. Parsonnet J; Gillis ZA; Pier GB J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924 [TBL] [Abstract][Full Text] [Related]
6. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome. Crass BA; Bergdoll MS J Clin Microbiol; 1986 Jun; 23(6):1138-9. PubMed ID: 3711305 [TBL] [Abstract][Full Text] [Related]
8. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Bonventre PF; Heeg H; Cullen C; Lian CJ Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600 [TBL] [Abstract][Full Text] [Related]
9. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock. De Boer ML; Kum WW; Pang LT; Chow AW Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917 [TBL] [Abstract][Full Text] [Related]
10. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918 [TBL] [Abstract][Full Text] [Related]
11. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay. Rosten PM; Bartlett KH; Chow AW J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118 [TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus producing toxic shock syndrome toxin 1 (TSST-1) in clinical specimens and vaginal swabs in Mannheim, West Germany. Dickgiesser N; Brombacher A Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):323-9. PubMed ID: 3314262 [TBL] [Abstract][Full Text] [Related]
15. Toxic shock syndrome--the role of the toxin. Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991 [TBL] [Abstract][Full Text] [Related]
16. The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study. Pierson JD; Hansmann MA; Davis CC; Forney LJ Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29762733 [TBL] [Abstract][Full Text] [Related]
17. Production of toxic shock syndrome toxin-1 (TSST-1) by Staphylococcus aureus strains isolated from humans, animals and foods in Nigeria. Adesiyun AA; Lenz W; Schaal KP Microbiologica; 1992 Apr; 15(2):125-33. PubMed ID: 1602983 [TBL] [Abstract][Full Text] [Related]
18. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection. Jacobson JA; Kasworm E; Daly JA Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655 [TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome. De Boer ML; Kum WW; Chow AW Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients. Park JY; Kim JS; Woo H Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]